02
DPP-4 Inhibitors and Brain Health: What the Latest Research Says About Sitagliptin and Dementia Risk
A growing body of research is examining whether DPP-4 inhibitors like sitagliptin may influence cognitive health in older adults with type 2 diabetes. The findings are nuanced, sometimes conflicting, and carry real implications for long-term treatment planning. This article breaks down the current evidence and what it means for patients navigating both diabetes and dementia risk.